BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5260 related articles for article (PubMed ID: 16548114)

  • 1. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oseltamivir: new preparation. An antiviral agent with little impact on influenza.
    Prescrire Int; 2003 Jun; 12(65):85-8. PubMed ID: 12825569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
    Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
    J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best.
    Prescrire Int; 2007 Feb; 16(87):9-11. PubMed ID: 17323516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza.
    Uyeki TM
    Pediatr Infect Dis J; 2003 Feb; 22(2):164-77. PubMed ID: 12586981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination].
    Uhnoo I; Linde A
    Lakartidningen; 2005 Dec 5-11; 102(49):3802-3, 3805-6, 3808. PubMed ID: 16408704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
    de Jong JC; Beyer WE; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):73-9. PubMed ID: 14753128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated treatment for influenza A and B.
    Montalto NJ; Gum KD; Ashley JV
    Am Fam Physician; 2000 Dec; 62(11):2467-76. PubMed ID: 11130232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents.
    Whitley RJ; Monto AS
    J Infect Dis; 2006 Nov; 194 Suppl 2():S133-8. PubMed ID: 17163386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
    Höffken G; Gillissen A
    Med Microbiol Immunol; 2002 Dec; 191(3-4):169-73. PubMed ID: 12458354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase inhibitors for treatment of influenza A and B infections.
    MMWR Recomm Rep; 1999 Dec; 48(RR-14):1-9. PubMed ID: 10632443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zanamivir. No noticeable progress against influenza.
    Can Fam Physician; 2000 Oct; 46():2003-8, 2012-8. PubMed ID: 11184246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy and prophylaxis for influenza in children.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Apr; 119(4):852-60. PubMed ID: 17403862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zanamivir: new preparation. No tangible progress against influenza.
    Prescrire Int; 2000 Feb; 9(45):199-202. PubMed ID: 11503795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Critical review of anti-influenza drugs].
    van Loon FP; Voordouw AC; Simonian S; Koopmans PP
    Ned Tijdschr Geneeskd; 2000 Jan; 144(4):165-7. PubMed ID: 10668542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influenza].
    Calza L; Briganti E; Manfredi R; Chiodo F
    Recenti Prog Med; 2000 Dec; 91(12):657-66. PubMed ID: 11194487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A
    Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic predictors of influenza virus positivity in children during the influenza season.
    Ohmit SE; Monto AS
    Clin Infect Dis; 2006 Sep; 43(5):564-8. PubMed ID: 16886147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 263.